Skuldtech is specialized in the discovery of genomic and transcriptomic biomarkers. To reach its objectives, the company uses quantitative RT-PCR technology for monitoring patterns of expressed genes.
Regarding the range of molecular biology and genomic technologies available in the field of Life Sciences, including Modern Medicine, Veterinary Science, Food-stuff, Agriculture, etc., the need for performing quantitative analyses of genes or DNA sequences has dramatically increased.
Skuldtech has gained tremendous experience in quantitative RT-PCR analysis.
In a high throughput routine, Skuldtech uses real-time PCR for monitoring global patterns of gene expression.
Real-time PCR provides an absolute quantitative analysis of gene expression and a rapid and precise confirmation of genetic changes.
Skuldtech’s expertise is focused on quantitative Real-Time PCR because this technique:
Is the most sensitive technique for mRNA detection and quantification currently available.
Can be used to quantify mRNA levels from much smaller samples.
Gives more accurate measurements and is much better adapted to analyses performed on large numbers of samples.
Has been successfully developed and has become a reliable and easy to use standard method for the detection
and/or quantification of nucleic acid sequences.
Reduces hands-on time and increases reliability.
Has been adopted for a wide range of new applications.
Skuldtech is specialized in the discovery of
new Biomarkers and the development of Diagnostics
focused on personalized medicine applications.
This expertise enables the company to provide genomic, pharmacogenomic and transcriptomic services, as well as innovative diagnostics
associated with new treatments, especially in
cancer, neurodegenerative and infectious diseases.